Plakophilin 1-deficient cells upregulate SPOCK1: implications for prostate cancer progression
- 320 Downloads
Plakophilin (PKP) 1 is frequently downregulated in prostate cancer and therefore may play a tumor-suppressive role. In the present study, we stably knocked down PKP1 in the non-neoplastic, prostatic BPH-1 cell line. In the PKP1-deficient cells, the expression of keratin 14 was lost, and the apoptosis rate was significantly reduced indicating that the cells acquired new biological capabilities. Moreover, we analyzed the gene expression profile of the PKP1-deficient BPH-1 cells. Among the genes that were significantly altered upon PKP1 knockdown, we noticed several extracellular matrix (ECM)-related genes and identified sparc/osteonectin, cwcv, and kazal-like domains proteoglycan 1 (SPOCK1/testican-1) as a gene of interest. SPOCK1 is a component of the ECM and belongs to a matricellular protein family named secreted protein, acidic, cysteine-rich (SPARC). The role of SPOCK1 in prostate cancer has not been clearly elucidated. We analyzed SPOCK1 mRNA expression levels in different cancer databases and characterized its expression in 136 prostatic adenocarcinomas by immunohistochemistry and western blot. SPOCK1 revealed a cytoplasmic localization in the glandular epithelium of the prostate and showed a significant upregulation of mRNA and protein in prostate tumor samples. Our findings support the hypothesis that PKP1 may have a tumor-suppressive function and suggest an important role of SPOCK1 in prostate tumor progression. Collectively, altered expression of PKP1 and SPOCK1 appears to be a frequent and critical event in prostate cancer.
KeywordsProstate cancer PKP1 SPOCK1 Extracellular matrix Testican-1
This study was funded by grants from the German Cancer Aid (109248) and the “Deutsche Forschungsgemeinschaft” (HO 2455/3-1). Cheng Yang obtained a fellowship from the Chinese Scholarship Council (CSC). We thank the microarray unit of the DKFZ Genomics and Proteomics Core Facility for providing the Illumina Whole-Genome Expression Beadchips and related services.
Conflicts of interest
- 15.Valladares-Ayerbes M, Diaz-Prado S, Reboredo M, Medina V, Lorenzo-Patino MJ, Iglesias-Diaz P, et al. Evaluation of plakophilin-3 mRNA as a biomarker for detection of circulating tumor cells in gastrointestinal cancer patients. Cancer Epidemiol Biomarkers Prev. 2010;19(6):1432–40.CrossRefPubMedGoogle Scholar
- 25.Bode W, Huber R. Proteinase-protein inhibitor interaction. In: Sies H, Flohé L, Zimmer G, editors. Molecular aspects of inflammation. Colloquium der gesellschaft für biologische chemie 11–13 April 1991 in Mosbach/Baden. Heidelberg: Springer Berlin; 1991. p. 103–15.Google Scholar